Mycobacterium smegmatis is a suitable cell factory for the production of steroidic synthons.
Ontology highlight
ABSTRACT: A number of pharmaceutical steroid synthons are currently produced through the microbial side-chain cleavage of natural sterols as an alternative to multi-step chemical synthesis. Industrially, these synthons have been usually produced through fermentative processes using environmental isolated microorganisms or their conventional mutants. Mycobacterium smegmatis mc2 155 is a model organism for tuberculosis studies which uses cholesterol as the sole carbon and energy source for growth, as other mycobacterial strains. Nevertheless, this property has not been exploited for the industrial production of steroidic synthons. Taking advantage of our knowledge on the cholesterol degradation pathway of M. smegmatis mc2 155 we have demonstrated that the MSMEG_6039 (kshB1) and M
SUBMITTER: Galan B
PROVIDER: S-EPMC5270728 | biostudies-literature | 2017 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA